Related Experiment Videos
[Anorectic syndrome]
1Sektion Ernährungsmedizin und Diätetik, Abt. Innere Medizin 1, Universitätsklinikum Freiburg, Germany. zuercher@mm11.ukl.uni-freiburg.de
Zeitschrift Fur Gastroenterologie
|April 4, 2002
Summary
Cancer patients often experience anorexia, a complex syndrome of appetite loss and taste changes. Its multifactorial causes and various treatment options are crucial for managing malignant diseases.
Area of Science:
- Oncology
- Gastroenterology
- Nutrition Science
Context:
- Anorectic syndrome is a common symptom in patients with malignant diseases.
- It involves appetite loss, food aversion, and sensory disturbances.
- Anorexia prevalence increases with tumor stage, affecting ~40% at diagnosis.
Purpose:
- To define anorectic syndrome in cancer patients.
- To explore the multifactorial etiology of cancer-induced anorexia.
- To outline current treatment strategies for anorexia in malignancy.
Summary:
- Anorexia in cancer is characterized by decreased food intake (<80% usual).
- Causes are diverse, including tumor-specific factors, metabolic changes, psychological elements, and treatment side effects.
- Nutritional interventions and pharmacotherapy (prokinetics, corticosteroids, gestagens, cannabinoids) are key treatment approaches.
Impact:
- Understanding anorexia is vital for improving cancer patient quality of life.
- Effective management can mitigate malnutrition and treatment complications.
- Further research into anorexia's complex mechanisms can lead to novel therapeutic targets.